Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML

In relapsed/refractory acute myeloid leukemia (AML), the prognostic impact of complete remission (CR) and measurable residual disease (MRD) negativity is not well established. We retrospectively analyzed 141 patients with relapsed/refractory AML who received first salvage therapy and had MRD assesse...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Blood Adv
Main Authors: Short, Nicholas J., Rafei, Hind, Daver, Naval, Hwang, Hyunsoo, Ning, Jing, Jorgensen, Jeffrey L., Kadia, Tapan M., DiNardo, Courtney D., Wang, Sa A., Jabbour, Elias, Popat, Uday, Oran, Betul, Cortes, Jorge, Konopleva, Marina, Yilmaz, Musa, Issa, Ghayas C., Kantarjian, Hagop, Ravandi, Farhad
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2020
Fag:
Clinical Trials and Observations
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7757010/
https://ncbi.nlm.nih.gov/pubmed/33351107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002811
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker